GLIMITERIS TRIO 0.5/0.2/500: Triple Action Therapy for Effective Type 2 Diabetes Control

Managing type 2 diabetes effectively often requires a combination of lifestyle changes and medication. GLIMITERIS TRIO 0.5/0.2/500, containing Glimepiride 0.5 mg, Voglibose 0.2 mg, and Metformin Hydrochloride (SR) 500 mg, is a carefully formulated combination tablet designed to provide comprehensive blood sugar control. This combination is especially useful for patients whose blood sugar levels are not adequately controlled by a single medication.

Manufactured by Steris Healthcare Pvt. Ltd., a trusted pharmaceutical company, GLIMITERIS TRIO ensures quality, safety, and efficacy, making it a reliable option for diabetes manageme

GLIMITERIS TRIO 0.5/0.2/500 is an oral anti-diabetic medication that combines three active ingredients:

1. Glimepiride 0.5 mg – A sulfonylurea that stimulates the pancreas to release insulin.

2. Voglibose 0.2 mg – An alpha-glucosidase inhibitor that slows carbohydrate absorption in the intestines.

3. Metformin Hydrochloride (SR) 500 mg – A biguanide that improves insulin sensitivity and reduces glucose production in the liver.

This triple-action combination works synergistically to control both fasting and post-meal blood glucose levels, providing superior glycemic control.

Uses of GLIMITERIS TRIO

GLIMITERIS TRIO is indicated for:

• Type 2 Diabetes Mellitus: Helps maintain fasting and postprandial blood glucose levels.

• Combination Therapy: Suitable for patients not adequately managed on monotherapy.

• Preventing Complications: Consistent blood sugar control reduces risks of cardiovascular, renal, and nerve complications.

• Adjunct to Lifestyle Modifications: Works best when combined with diet and exercise.

How GLIMITERIS TRIO Works

Each component of GLIMITERIS TRIO has a distinct mechanism of action:

1. Glimepiride – Stimulates pancreatic beta cells to release insulin, lowering blood sugar levels.

2. Voglibose – Delays the absorption of glucose from the intestines, reducing post-meal spikes in blood sugar.

3. Metformin (SR) – Suppresses hepatic glucose production, increases insulin sensitivity in peripheral tissues, and enhances glucose uptake.

This combination provides a balanced approach to managing both fasting and postprandial blood sugar, improving overall glycemic control.

Dosage and Administration

• Typical dose: One tablet once or twice daily, as prescribed by your healthcare provider.

• Administration: Swallow the tablet whole with water, preferably with meals to reduce gastrointestinal side effects.

• Individualization: Dosage may be adjusted based on patient response and blood sugar monitoring.

• Monitoring: Regular blood sugar and periodic kidney and liver function tests are recommended.

Benefits of GLIMITERIS TRIO

1. Effective Glycemic Control: Targets both fasting and post-meal blood sugar levels.

2. Convenience: Combines three medications in a single tablet, improving adherence.

3. Reduced Risk of Complications: Consistent control lowers the risk of diabetic complications.

4. Synergistic Effect: Each ingredient complements the other for comprehensive diabetes management.

5. Sustained Release Formulation: Metformin SR provides longer action, reducing the frequency of doses.

Side Effects

Common side effects:

• Nausea, vomiting, or stomach upset

• Diarrhea or mild abdominal discomfort

• Headache or dizziness

• Mild weight gain (mainly due to Glimepiride)

Serious side effects:

• Hypoglycemia (low blood sugar) – Symptoms include sweating, shakiness, and confusion.

• Rare liver or kidney dysfunction

• Allergic reactions (rash, itching, swelling)

Patients should report any unusual or severe side effects to their healthcare provider immediately.

Precautions and Safety Information

• Take GLIMITERIS TRIO only as prescribed.

• Inform your doctor if you have kidney, liver, or heart conditions.

• Pregnant or breastfeeding women should use this medication only under medical supervision.

• Avoid skipping meals to prevent hypoglycemia.

• Limit alcohol consumption as it may increase the risk of low blood sugar.

• Regular monitoring of blood glucose and HbA1c is recommended.

Why Choose Steris Healthcare Pvt. Ltd.?

Steris Healthcare is renowned for quality, safety, and patient-centric pharmaceutical solutions. Choosing GLIMITERIS TRIO from Steris Healthcare ensures:

• WHO-GMP Certified Manufacturing: Adhering to international quality standards.

• Clinically Proven Formulation: Trusted combination therapy for type 2 diabetes.

• Patient Convenience: Single tablet with sustained-release formulation.

• Reliable Availability: Accessible across India at competitive pricing.

• Trusted Brand Reputation: Steris Healthcare has a long-standing commitment to patient safety and efficacy.

Tips for Patients

• Take your medication consistently at the same time daily.

• Follow a balanced diet and regular exercise routine.

• Monitor blood sugar levels regularly.

• Maintain a diabetes log to track medication response and lifestyle changes.

• Consult your doctor before combining with other medications.

Frequently Asked Questions

1. What is GLIMITERIS TRIO 0.5/0.2/500 used for?
It is used to manage type 2 diabetes by controlling both fasting and postprandial blood glucose levels.

2. Can it cause low blood sugar?
Yes, hypoglycemia may occur, especially if meals are skipped or during excessive physical activity.

3. Can it be used long-term?
Yes, under medical supervision, this combination can be used long-term for sustained glycemic control.

4. How should I take the medication?
Swallow the tablet with water, preferably with meals. Do not crush or chew.

5. Are there any interactions with other medicines?
Always inform your doctor about other medications you are taking, as Glimepiride, Voglibose, and Metformin may interact with certain drugs.

6. Can it be used during pregnancy or breastfeeding?
Only under strict medical supervision. Consult your healthcare provider.

Conclusion

GLIMITERIS TRIO 0.5/0.2/500 offers a comprehensive approach to type 2 diabetes management, targeting both fasting and post-meal blood sugar levels through its triple-action formulation. Manufactured by Steris Healthcare Pvt. Ltd., it combines safety, efficacy, and convenience, making it an ideal choice for patients looking for reliable diabetes control.

For those seeking clinically proven therapy, enhanced adherence, and long-term blood sugar management, GLIMITERIS TRIO 0.5/0.2/500 provides a trusted solution that improves overall quality of life and reduces the risk of complications.